Introduction
Kikuchi-Fujimoto disease is an uncommon form of reactive lymphadenopathy, which was Wrst described in Japan in 1972 [1, 2] . Since then it has been recognized in many other countries worldwide as a self-limited syndrome characterized by lymphadenopathy [3] [4] [5] [6] . It usually aVects young females presenting with localized-predominantly cervical-lymphadenopathy, which is frequently associated with fever. The diagnosis is based on the histologic Wndings. The histologic picture is characterized by karyorrhectic foci, usually with coagulative necrosis without neutrophilic inWltration, and the presence of histiocytes and immunoblasts [3] . It may resemble to that observed in systemic lupus erythematosus (SLE), but may also be misdiagnosed as malignant lymphoma [3, 7] . An association between Kikuchi's lymphadenopathy and SLE or other autoimmune conditions has been reported in some cases. In this study, we present our experience with this rare disorder in a single center in Greece.
Patients and methods
We report nine cases of Kikuchi's disease diagnosed in the Haematology Unit, First Department of Internal Medicine, Athens University from 1990 to 2006 in adult or adolescent patients. Four of these cases were part of a series of 516 consecutive patients with lymphadenopathy, which has been previously published [8] . During the same period there was also an additional case of SLE, who reported a history of Kikuchi's disease 7 years prior to her presentation. The clinical and laboratory features were not available and this case was not included in this analysis.
Demographic, clinical and laboratory data were extracted from the medical records of the patients. The diagnosis was based on lymph node histological examination in all cases. All patients underwent laboratory testing with complete blood count and diVerential, chest X-rays, Epstein-Barr virus (EBV), cytomegalovirus (CMV) and Toxoplasma gondii serology. Most patients were also tested for erythrocyte sedimentation rate (ESR), biochemical proWle, serum protein electrophoresis and the presence of rheumatoid factor, antinuclear and anti-ds DNA antibodies as well as serum complement levels. Other tests were performed in less than half of the patients. Computed tomography and bone marrow biopsy were not routinely performed. Clinically signiWcant anemia was deWned as hemoglobin levels <115 g/l, while clinically signiWcant thrombocytopenia as platelet counts <100 £ 10 9 /l. Leucopenia was deWned as white blood cell count <4 £ 10 9 /l and neutropenia as an absolute neutrophil count of less than 1.8 £ 10 9 /l, while lymphocytopenia was deWned as an absolute lymphocyte count of less than 1.5 £ 10 9 /l.
Results

Clinical, laboratory and histologic Wndings
The demographic, clinical and laboratory data of the patients are summarized in Tables 1, 2 and 3 . Seven patients were native Greeks, one was Phillipinian and one Kenyan. Both non-Greek patients were living in Greece for more than 10 years. The median age of the patients was 25 years (14-40) and 8/9 of them (89%) were females. All patients presented with cervical lymphadenopathy, seven patients had fever (78%; in one case low grade only), while two were asymptomatic and presented with incidentally discovered lymphadenopathy. The median duration of lymphadenopathy before presentation was 30 days (range 10-45). Splenomegaly was recorded in three patients (33%), but the spleen was just palpable below the left costal margin in all three cases. One patient had palpable mild hepatomegaly, conWrmed by ultrasonography. Each one of fatigue, sorethroat, sweats, arthralgias and headache was reported by two patients, while a rash was recorded in a single case. Cervical lymphadenopathy was observed in all nine patients, being unilateral in Wve (left 2; right 3) and bilateral in four cases. The submandibular lymph nodes were involved in three cases. Supraclavicular nodes were not enlarged in any case. Eight patients had lymphadenopathy restricted to the cervical areas, while a single patient had bilateral axillary lymph nodes up to 1 £ 1 cm, which resolved later. The median value of the maximal lymph node diameter was 2 cm (range 1-5 cm), but only one out of the nine patients had lymph nodes greater than 2 cm in their maximal diameter. Lymphadenopathy was tender in two (out of seven) patients. Hard lymph nodes were observed in three (out of eight) patients.
According to the clinical prediction rule published by our group [9] , only a single patient was considered to be in need of lymph node biopsy. This was due to the large size (5 cm) and the hard texture of the neck mass in patient #3. However, all patients Wnally underwent a lymph node biopsy. This decision was based on empirical clinical judgment due to prolonged non-remitting lymphadenopathy. BrieXy, the histologic Wndings of the nine cases were as follows: Lymph node architecture was completely eVaced in three and partially preserved in six cases. Necrosis was present in all cases (patchy in seven and conXuent in two), associated with apoptotic cells and nuclear karyorrhectic debris. Aggregates of histiocytes were observed in all cases (numerous in 7/9) as well as activated T-lymphocytes (numerous in 4/9) and plasmacytoid monocytes. Neutrophils and eosinophils were not observed in any case.
The median leukocyte count was 4.7 £ 10 9 /l (2.2-4.9); all patients had low or low-normal leukocyte counts. Leucopenia or low-normal leukocyte counts with normal diVerential were recorded in seven patients. The remaining two patients presented with inversion in diVerential leukocyte counts. The median neutrophil count was 1.7 £ 10 9 /l (1.1-3.2); 5/9 patients (56%) had neutropenia. The median lymphocyte count was 1.6 £ 10 9 /l (0.8-2.9); 4/9 (44%) patients had lymphocytopenia. Clinically signiWcant anemia was observed in three patients (33%). No case of clinically signiWcant thrombocytopenia was observed. The median ESR was 51.5 mm/h (5-65), and ESR was ¸30 mm/h in 6/8 patients (75%). Serum lactate dehydrogenase (LDH) levels were elevated in 4/6 (67%) patients and elevated aminotransferase levels were recorded in 2/6 (33%) patients. However, in patient #9 the clinical course was complicated by signiWcant transaminasemia (5-10x), which led to a nondiagnostic liver biopsy, despite the normal initial transaminase levels. Polyclonal hypergammaglobulinemia was observed in 4/8 patients (50%). The hematologic and biochemical Wndings in this series of patients with Table 2 . Baseline chest X-rays did not reveal abnormal Wndings in any case, although patient #9 developed severe pneumonia and pleuritis due to Pseudomonas aeruginosa during her hospitalization, which resolved with the appropriate antimicrobial treatment. Serum tests for current infection by Epstein-Barr virus (VCA-EBV) and cytomegalovirus were performed in all patients, and were consistently negative (Table 3) . Among nine patients, eight had no evidence of current toxoplasmic infection and one had a stable IgM titer of 1/150 with negative IgG. This was considered as a false positive result. Other serological tests for various infectious agents, including herpes simplex and Yersinia enterocolitica, were negative, when performed (Table 3) .
Serological workup for autoimmune disorders is also summarized in Table 3 . Two patients tested positive for antinuclear antibodies at titers 1/80 speckle and 1/160 diVuse. The former patient (#8) had a borderline antidsDNA result and a positive IgM anticardiolipin (41.3, 57.3 and 41 vs. normal limit <12.5 MPLU/ml, in serial measurements over 14 months) and 2 -GPI assay (39.4 vs. normal limit <15), while the initially normal IgG anticardiolipin increased later on (9.9 and 38 vs. normal limit <15 GPLU/ ml). Lupus anticoagulant was negative. This patient had also marked polyclonal hypergammaglobulinemia. During the evaluation of febrile lymphadenopathy she also developed thrombosis of the superior vena cava, while she had reported a history of two consecutive spontaneous abortions. A subsequent work-up for thrombophilia was negative. Thus a diagnosis of primary antiphospholipid syndrome (APLS) was established [10] , since she did not fulWll the diagnostic criteria for SLE. At 1-year follow-up visit she was afebrile, with persistent serologic abnormalities, but no evidence of SLE. In the second patient (#9) antinuclear antibodies disappeared after the resolution of Kikuchi's lymphadenopathy, while she did not fulWll the diagnostic criteria for SLE at any timepoint. Leukocyte counts and diVerential are reported in Table 1 a Only a single case with hemoglobin levels <10 g/dl (9.8 g/dl) b 126 £ 10 9 /l c Above the upper normal limit of the laboratory 
Follow-up
In all patients lymphadenopathy resolved without speciWc treatment. None of the patients developed SLE during the initial observation phase, usually of 6-12 month duration. Long term follow-up beyond this phase was available for four patients, all of whom were in excellent clinical condition at a median of 8.5 years after the diagnosis (range 2.5-15).
Cases of recurrent Kikuchi's disease or comorbid conditions have not been observed, with the exception of the synchronous APLS in patient #8, and the Pseudomonas pneumonia which complicated the clinical course of patient #9.
Discussion
Although Kikuchi's lymphadenopathy was originally described in Japan 35 years ago, it has been reported worldwide during the last 25 years [1] [2] [3] [4] [5] [6] . The true incidence of Kikuchi's lymphadenopathy in unselected series of adult patients presenting with lymphadenopathy is not known.
Figures up to 5.7% of all lymph node biopsies have been reported in Asia, reXecting the increased local incidence of the disease, but actually refer to highly selected populations of patients with clinically signiWcant lymphadenopathy requiring a lymph node biopsy [11] . Except of case reports, published experience with Kikuchi's disease in Greece is limited [4] . Among nine patients presented here, four had been part of a series of 516 consecutive, unselected, patients, who presented with lympadenopathy in a single Haematology Unit [8] . On the basis of these data, the estimated frequency of Kikuchi's disease was 0.8% among patients presenting with lymphadenopathy in a teaching hospital in Greece. However, the self-limited course of the disease may lead to underestimation of its true incidence, since, in an unknown fraction of patients, the disease may resolve prior to the Wnal decision to perform a lymph node biopsy. The etiology of Kikuchi's lymphadenopathy remains unknown. Several infectious agents have been proposed as potential causes of the disease but clear evidence is lacking. On the basis of serologic Wndings, Kikuchi's lymphadenopathy has been associated with Toxoplasma gondii, Yersinia enterocolitica, HTLV-1 and hepatitis C virus, while EBV and human herpesvirus-6 and 8 (HHV-6 and HHV-8) have been detected by polymerase chain reaction or in situ hybridization [3, 12] . Rubella, brucellosis and parvovirus B19 have also been associated with Kikuchi's disease [3, 13] . However, all these associations are either rare or have not been conWrmed by alternative laboratory methods. In the present series, there was no serologic evidence for the implication of infectious agents in the pathogenesis of the disease, as shown in Table 3 . It must be stressed out that the reported Pseudomonas pneumonia was not considered as the cause of Kikuchi's disease in patient #9. We rather believe that it was a complication of the disease, which was already present for almost 45 days.
In a review of 108 predominantly American cases of Kikuchi's lymphadenopathy [7] the median age was 30 years, almost 95% of the patients were younger than 40 years, and the male to female ratio was 1:4. Fever complicated the clinical picture in 39% of the patients, weight loss and sweats in 10-15% of the patients, but other symptoms, except of local ones, were recorded with frequencies of less than 5%. The mean duration of the symptoms was 3 months (range 1-24). In 81% of the patients, lymphadenopathy was localized, in 14% it was limited to two sites, and was more generalized in only 6% of the patients.
In another report of 58 patients from Taiwan [14] , the mean age was 25 years and the male to female ratio was 1:1.76. Fever complicated the clinical picture in 43% of the patients, sore throat was recorded in 21%, but weight loss and night sweats were very rare (3 and 2% of the patients, respectively). The median duration of symptoms was 4 weeks. All patients had cervical lymphadenopathy (usually posterior and 21% bilateral) and only 5% had axillary lymphadenopathy. Thus, approximately 95% of the patients had 1 or 2 involved nodal sites. Small nodes, <2 cm, were recorded in 75% of the patients (range 0.5-9 cm) and tenderness in 50%, while splenomegaly was very rare (3%).
Our data conWrm that patients suVering from this selflimited condition are mainly young females, presenting with predominantly cervical lymphadenopathy sparing the supraclavicular fossa. The disease is frequently febrile. Leucopenia or low-normal leukocyte counts with normal diVerential are the rule. Although not diagnostic, this combination of the demographic, clinical and laboratory features should raise the suspicion of Kikuchi's disease in patients with unexplained lymphadenopathy. The marked predilection to the involvement of cervical lymph nodes and the young age of the patients is clear [7, 14] ; however, female predominance may be less prominent in Asia than in Europe or USA [14] .
The diagnosis of Kikuchi's disease is based on the histologic Wndings. Histological examination reveals partial maintenance of the lymph node architecture, with the presence of reactive germinal centers in residual follicles. There are patchy areas of irregularly shaped necrosis, which is occasionally conXuent. The necrosis consists of eosinophilic Wbrinoid deposits including nuclear fragments and is surrounded by large accumulations of histiocytes, phagocytosing the aforementioned cellular debris. These areas of histiocytic aggregates also include small lymphocytes, activated large T lymphocytes, scarce plasma cells and nests of plasmacytoid monocytes. The consistent absence of neutrophils and eosinophils, as in our cases, is a distinctive feature of Kikuchi's disease. Reliable cytological diagnosis has been reported in half of the patients in one study, but it cannot substitute lymph node biopsy [15] . All of our patients actually underwent a lymph node biopsy. Based on the clinical prediction rule published by our group [9] , only one patient fulWlled the criteria to undergo a lymph node biopsy, while in the remaining patients the decision was made on the basis of clinical judgment, due to the presence of "suspicious", persistent, unexplained lymphadenopathy. This clinical prediction rule was developed in order to facilitate the diVerentiation between serious and non-serious lymphadenopathy. In this sense, failure to classify patients with Kikuchi's disease in the group of patients predicted to be in need of biopsy is consistent with the benign, "nonserious" nature of the disease.
From the clinical point of view, Kikuchi's lymphadenopathy raises problems of diVerential diagnosis, because of its subacute presentation with a picture reminiscent of Hodgkin's or non-Hodgkin's lymphoma, dominated by limited, usually cervical lymphadenopathy in febrile patients with elevated ESR and possibly elevated serum lactate dehydrogenase (LDH) levels. However, the absence of supraclavicular lymphadenopathy and mediastinal enlargement, the frequently small size of enlarged nodes (less than or equal to 2 cm in all but one case in this study), the low or low-normal leukocyte count with normal diVerential and the absence of other cytopenia or thrombocytosis may facilitate the clinical distinction between lymphoma and Kikuchi's disease in most cases. Extensive diagnostic work-up with computed tomography, bone marrow biopsy or other tests beyond that needed for the clariWcation of the cause of lymphadenopathy is not justiWed for the vast majority of cases of Kikuchi's disease.
At the histologic level the presence of T-immunoblasts, occasionally bearing atypical morphologic features, in Kikuchi's disease may result to confusion with aggressive non-Hodgkin's lymphomas, mainly of the T-cell phenotype. CD8+ cells predominate in Kikuchi's disease, while the majority of the T-cell lymphomas are CD4+ rather CD8+. Clues for the diVerential diagnosis between the two entities are given in Table 4 . The presence of fever with [3, [16] [17] [18] [19] . In a review of 35 cases, SLE developed after the diagnosis of Kikuchi's disease in 14 and concomitantly with the disease in 14, while Kikuchi's developed after SLE in seven patients [20] . Thus, SLE should carefully be excluded both serologically and histologically in every patient with Kikuchi's disease. SLE-associated lymphadenopathy can be histologically diVerentiated from Kikuchi's disease on the basis of the presence of hematoxylin bodies, neutrophils, vasculitic lesions, the Azzopardi phenomenon and the abundance of plasma cells (see Table 4 ). However, these clear features may not always be present, leading to diagnostic problems. Whether SLE really complicates the course of a small minority of patients with Kikuchi's lymphadenopathy or these cases actually represent examples of misdiagnosis at the initial presentation of SLE with lymphadenopathy is unclear [3] . However, although the clinical Wndings usually resolve rapidly, prolonged followup is needed after a diagnosis of Kikuchi's lymphadenopathy has been established, in order to detect rare cases, who might develop SLE.
In our series, SLE did not develop in any patient after the diagnosis of Kikuchi's disease. It must be pointed out that during the study period, one patient presented with SLE and reported an episode of Kikuchi's lymphadenopathy 7 years prior to the diagnosis. This patient was not included in the study because there was no histologic veriWcation available to conWrm that the patient had indeed Kikuchi's disease and not lupus lymphadenitis. However, 2/7 patients tested had positive antinuclear antibodies and 1/3 tested had antithyroid antibodies, suggesting a relation of Kikuchi's disease with autoimmunity, which is more clearly shown in previously reported studies.
In this context, one of the nine patients reported here actually had primary APLS, which was diagnosed concomitantly with Kikuchi's lymphadenopathy. This patient did not fulWll the diagnostic criteria for SLE. There are three recent additional case reports linking Kikuchi's lymphadenopathy with the APLS, either primary or secondary to SLE [21] [22] [23] . Thus, the APLS should also be looked for in patients with Kikuchi's lymphadenopathy, since it may coexist with Kikuchi's disease.
In conclusion, Kikuchi's disease represents a rare but important diagnostic possibility for patients presenting with lymphadenopathy in Greece and other western countries. The wider recognition of this self-limited entity would result to less extensive diagnostic work-up, appropriate testing for possible underlying autoimmune disease (mainly SLE, but also APLS and probably other entities), avoidance of hospitalization and proper medical consultation regarding the required follow-up.
